The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...
The US Food and Drug Administration turned down a self-administered version of AstraZeneca Plc’s lupus medicine, but the UK drugmaker said it’s still working with regulators to advance the request.
Harm reduction initiatives, like syringe services programs, can reduce HIV transmission among people who inject drugs. A recent executive order threatens such programs. (Photo by Robert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results